Tata Capital Unlisted Shares
Tata Capital’s healthcare arm invests $10 million in Apex Kidney Care
mint
2 min read
Apex Kidney Care: $10M Funding Boosts Vital Dialysis Service Expansion
Expert Analysis:
Apex Kidney Care's successful funding round securing $10 million from Tata Capital Healthcare Fund underscores India's growing demand for quality kidney care services.
The investment showcases confidence in the sector's potential and paves the way for the expansion of vital dialysis services.
This aligns with the recent activity in the nephrology space, reflecting a positive outlook for healthcare investments.
Investor Confidence: Apex Kidney Care receives $10 million in funding from Tata Capital Healthcare Fund to expand dialysis services.
Healthcare Investment Outlook: The investment highlights the increasing demand for quality kidney care services in India.
Vital Service Expansion: It signifies positive prospects for healthcare investments and the growth of essential dialysis services.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved